Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AMAG | ABUS | FATE | ||
| Company | Amag Pharmaceuticals | Arbutus Biopharma Cp | Fate Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 13.75 | 2.64 | 4.12 | ||
| High | 13.76 | 2.73 | 4.22 | ||
| Low | 13.75 | 2.63 | 3.92 | ||
| Last | 13.75 | 2.68 | 4.10 | ||
| Change | +0.02 | -0.01 | +0.01 | ||
| % Change | +0.15% | -0.37% | +0.24% | ||
| Volume | 1,534,500 | 673,200 | 3,311,900 | ||
| 20-Day Average Volume | 1,378,455 | 1,196,140 | 2,666,660 | ||
| Previous Close | 13.73 | 2.69 | 4.09 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 13.70 | 2.84 | 5.10 | ||
| 20-Day Raw Stochastic | 93.33% | 7.58% | 10.59% | ||
| 20-Day Relative Strength | 69.51% | 46.97% | 32.33% | ||
| Weighted Alpha | +24.20 | +10.32 | -52.75 | ||
| Today's Opinion | 100% Buy | 64% Buy | 8% Sell | ||
| Previous Opinion | 100% Buy | 64% Buy | 8% Sell | ||
| Last Month's Opinion | 100% Buy | 80% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.22% since 11/06/20 | -1.47% since 04/25/24 | +5.94% since 04/25/24 | ||
| Low | 13.71 on 11/10/20 | 2.63 on 05/02/24 | 3.74 on 04/26/24 | ||
| High | 13.76 on 11/13/20 | 2.80 on 04/29/24 | 4.33 on 05/01/24 | ||
| 1-Month | |||||
| %Chg | +2.84% since 10/13/20 | +6.35% since 04/02/24 | -39.71% since 04/02/24 | ||
| Low | 13.35 on 10/14/20 | 2.30 on 04/03/24 | 3.74 on 04/26/24 | ||
| High | 13.76 on 11/13/20 | 3.29 on 04/05/24 | 7.34 on 04/04/24 | ||
| 3-Month | |||||
| %Chg | +30.09% since 08/13/20 | +12.61% since 02/02/24 | -37.12% since 02/02/24 | ||
| Low | 8.62 on 09/24/20 | 2.30 on 04/03/24 | 3.74 on 04/26/24 | ||
| High | 13.80 on 10/01/20 | 3.29 on 04/05/24 | 8.83 on 03/07/24 | ||
| 6-Month | |||||
| %Chg | +87.33% since 05/13/20 | +48.07% since 11/02/23 | +85.52% since 11/02/23 | ||
| Low | 6.51 on 05/14/20 | 1.70 on 11/13/23 | 1.91 on 11/10/23 | ||
| High | 13.80 on 10/01/20 | 3.29 on 04/05/24 | 8.83 on 03/07/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 477,469 | 482,834 | 465,512 | ||
| Shares Outstanding, K | 34,725 | 179,492 | 113,817 | ||
| Annual Sales | 327,750,000 | 18,140,000 | 63,530,000 | ||
| Annual Net Income | -466,460,000 | -72,850,000 | -160,930,000 | ||
| Last Quarter Sales | 52,760,000 | 2,150,000 | 1,680,000 | ||
| Last Quarter Net Income | -13,240,000 | -19,310,000 | -44,120,000 | ||
| 60-Month Beta | 0.89 | 2.05 | 1.80 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.12 on 02/29/24 | -0.45 on 02/26/24 | ||
| Latest Earnings Date | 11/13/20 | 05/02/24 | 05/01/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||